QLT Inc. (QLTI) Reports Visudyne(R) Sales for Q4, FY08
Tweet Send to a Friend
QLT Inc. (NASDAQ: QLTI) today announced global Visudyne(R) (verteporfin) sales of $30.6 million for the quarter and $141.9 million for ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
